We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+23.97%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$69.6B
AUM Growth
+$8.07B
Cap. Flow
+$567M
Cap. Flow %
0.82%
Top 10 Hldgs %
16.2%
Holding
2,221
New
173
Increased
863
Reduced
913
Closed
183

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$436M
2
RF icon
Regions Financial
RF
+$313M
3
ADP icon
Automatic Data Processing
ADP
+$289M
4
INTU icon
Intuit
INTU
+$288M
5
NFLX icon
Netflix
NFLX
+$253M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Healthcare 13.59%
3 Industrials 13.09%
4 Financials 10.33%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRMD icon
1801
iRadimed
IRMD
$1.06B
$16.4K ﹤0.01%
172
+2
+1% +$182
ASAN icon
1802
Asana
ASAN
$2.21B
$16.3K ﹤0.01%
2,325
-610,583
-100% -$4.1M
RIGL icon
1803
Rigel Pharmaceuticals
RIGL
$847M
$15.8K ﹤0.01%
403
-498
-55% -$15.4K
ERIC icon
1804
Ericsson
ERIC
$32.8B
$15.2K ﹤0.01%
1,359
PRDO icon
1805
Perdoceo Education
PRDO
$2.07B
$15K ﹤0.01%
470
+68
+17% +$2.33K
EGHT icon
1806
8x8 Inc
EGHT
$266M
$14.8K ﹤0.01%
8,631
-501,936
-98% -$1.01M
PRAX icon
1807
Praxis Precision Medicines
PRAX
$9.23B
$14.7K ﹤0.01%
44
PANL icon
1808
Pangaea Logistics
PANL
$545M
$14.6K ﹤0.01%
+2,241
New +$17K
TRDA icon
1809
Entrada Therapeutics
TRDA
$275M
$14.5K ﹤0.01%
+1,968
New +$18.9K
HSBC icon
1810
HSBC
HSBC
$356B
$14.4K ﹤0.01%
151
-8
-5% -$730
NKTX icon
1811
Nkarta
NKTX
$209M
$14.3K ﹤0.01%
5,048
-937
-16% -$2.64K
INSG icon
1812
Inseego
INSG
$71.4M
$14.2K ﹤0.01%
1,371
+907
+195% +$12.2K
ABX
1813
Abacus Global Management
ABX
$928M
$14.1K ﹤0.01%
+1,321
New +$12.1K
NWS icon
1814
News Corp Class B
NWS
$18.2B
$14.1K ﹤0.01%
504
-8
-2% -$238
ACRV icon
1815
Acrivon Therapeutics
ACRV
$84M
$14.1K ﹤0.01%
7,924
WAT icon
1816
Waters Corp
WAT
$40.3B
$13.9K ﹤0.01%
37
+18
+95% +$6.14K
INSM icon
1817
Insmed
INSM
$27.4B
$13.9K ﹤0.01%
130
-538,127
-100% -$65.2M
DGRW icon
1818
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
$13.8K ﹤0.01%
+144
New +$13.6K
ALNT icon
1819
Allient
ALNT
$1.54B
$13.7K ﹤0.01%
133
+63
+90% +$4.86K
CVGI icon
1820
Commercial Vehicle Group
CVGI
$127M
$13.6K ﹤0.01%
2,938
-3,085
-51% -$14.5K
PLOW icon
1821
Douglas Dynamics
PLOW
$926M
$13.4K ﹤0.01%
248
+74
+43% +$3.41K
QTTB icon
1822
Q32 Bio
QTTB
$325M
$13.4K ﹤0.01%
1,050
-1,223
-54% -$10.2K
BEKE icon
1823
KE Holdings
BEKE
$18.4B
$13.2K ﹤0.01%
905
+57
+7% +$939
HYLN icon
1824
Hyliion Holdings
HYLN
$677M
$13K ﹤0.01%
2,489
-4,680
-65% -$19.5K
ALC icon
1825
Alcon
ALC
$32.7B
$12.9K ﹤0.01%
193

Similar funds

Federated Hermes's Q2 2026 Portfolio in Review

As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
  • Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
  • Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
  • Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
  • Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
  • Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.